等待開盤 08-06 09:30:00 美东时间
0.000
0.00%
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.
2024-05-15 01:32
Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc.
2023-10-11 21:25
New product in development diversifies portfolio to drive long-term growth Innovative potential new therapeutic option for rare/orphan neuropsychiatric disorders with high unmet medical nee...
2023-10-11 20:00
Canaccord Genuity analyst Sumant Kulkarni downgrades Zynerba Pharmaceuticals (NASDAQ:ZYNE) from Buy to Hold and lowers the price target from $10 to $1.11.
2023-08-16 17:50
NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2023-08-15 18:24
What is the target price for Zynerba Pharmaceuticals (ZYNE)?The latest price ta...
2023-08-15 07:36
GAINERS: Choom Holdings (OTC:CHOOF) shares closed up 900.00% at $0.0001 Zynerb...
2023-08-15 05:30
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The S&P 500, also rose, gaining, 0.28% to 4,476.67.
2023-08-15 02:52
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 80 points on Monday. The Dow traded up 0.01% to 35,284.34 while the NASDAQ rose 0.64% to 13,732.05. The S&P 500, also rose, gaining, 0.36% to 4,480.04.
2023-08-15 00:02
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) shares are surging higher Monday.
2023-08-14 23:21